An Affected Baby May Appear Normal

Newborns with metabolic disorders may not show any sign or symptoms at birth. It is likely undetected or misled to other diagnosis. Screening your newborn will facilitate early intervention and prevent long term detrimental effects to your baby’s health such as such as mental retardation, physical disability and in some instances, death, if it is left untreated.

Early detection for effective disease management.
Your baby’s first step to a healthy life.

Download infopack and contact us for more information!
What is Non-Invasive Prenatal Test (NIPT) ?

Non-invasive prenatal testing (“NIPT”) is a relatively new type of screening test that can tell more about your unborn baby than ever before.

In 1997, scientists first reported the presence of small amounts of baby’s DNA (known as cell-free DNA, or cfDNA) in the mother’s blood as early as four gestational weeks1 . The rapid development of next generation sequencing technology makes it possible to detect the risk of having chromosomal abnormalities including Down Syndrome, Patau Syndrome, Edwards Syndrome and other genetic conditions non-invasively.

The American Congress of Obstetricians and Gynecologists (ACOG) Recommends all pregnant women regardless of age to be offered screening for foetal chromosomal abnormalities.2

Enroling NICE® NIPT

NICE® NIPT must be prescribed by your obstetrician who will explain the details about NIPT to ensure the test is suitable for you.

Enquire Now